Aronex Pharma (ARNX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aronex Pharma (ARNX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sam Lee who wrote (226)	3/22/1999 8:18:00 PM
From: JMarcus	Read Replies (1) of 320

Sam, some folks may view your comment about ARNX becoming a teenager someday as vacuous cheerleading, but we shouldn't forget that this company used to be a teenager in 1996. quote.yahoo.com Third tier biotech companies like ARNX are grossly undervalued in the current market climate. ARNX's drug development program is so much further along now that it was in 1996, and yet its market cap is just a fraction of what it was three years ago. This disconnect between stock price and value won't last forever, or even much longer, IMO. Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next